Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 1
1979 2
1980 2
1981 3
1982 4
1983 4
1984 4
1985 3
1986 2
1987 7
1988 6
1989 2
1991 2
1993 2
1994 2
1995 1
1996 2
1997 3
1998 3
1999 6
2000 3
2001 2
2002 3
2003 1
2004 4
2005 4
2006 2
2007 3
2008 1
2009 2
2010 4
2011 3
2012 3
2013 4
2014 2
2015 8
2016 6
2017 2
2018 5
2019 5
2020 5
2021 5
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

133 results
Results by year
Filters applied: . Clear all
Page 1
Systemic Lupus Erythematosus Classification and Diagnosis.
Aringer M, Johnson SR. Aringer M, et al. Rheum Dis Clin North Am. 2021 Aug;47(3):501-511. doi: 10.1016/j.rdc.2021.04.011. Epub 2021 Jun 10. Rheum Dis Clin North Am. 2021. PMID: 34215376 Review.
Since the European League Against Rheumatism/American College of Rheumatology 2019 classification criteria for systemic lupus erythematosus (SLE) were published, they were externally validated by groups worldwide. In particular, the new criteria worked well a …
Since the European League Against Rheumatism/American College of Rheumatology 2019 classification criteria for systemic lupus
New insights into the role of antinuclear antibodies in systemic lupus erythematosus.
Pisetsky DS, Lipsky PE. Pisetsky DS, et al. Nat Rev Rheumatol. 2020 Oct;16(10):565-579. doi: 10.1038/s41584-020-0480-7. Epub 2020 Sep 3. Nat Rev Rheumatol. 2020. PMID: 32884126 Free PMC article. Review.
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by antinuclear antibodies (ANAs) that form immune complexes that mediate pathogenesis by tissue deposition or cytokine induction. ...Experience from clinical trials of novel t
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by antinuclear antibodies (ANAs) th
ANA-Negative Lupus Presenting with Heart Failure and Severe Valvular Dysfunction: Case Report and Review of the Literature.
Hoang V, Addison D, Lakkis N, Tabbaa R. Hoang V, et al. Methodist Debakey Cardiovasc J. 2015 Jul-Sep;11(3):186-8. doi: 10.14797/mdcj-11-3-186. Methodist Debakey Cardiovasc J. 2015. PMID: 26634028 Free PMC article. Review.
Antinuclear antibody (ANA) negative lupus is an important subset of the systemic lupus erythematosus (SLE) disease spectrum. Since the introduction of human cell line for ANA assay, the occurrence of true ANA-negative
Antinuclear antibody (ANA) negative lupus is an important subset of the systemic lupus erythematosus
ANA-negative systemic lupus erythematosus.
Pratap DV, Reddy SK, Rani SC, Krishna VA, Indira D. Pratap DV, et al. Indian J Dermatol Venereol Leprol. 2004 Jul-Aug;70(4):243-4. Indian J Dermatol Venereol Leprol. 2004. PMID: 17642626 No abstract available.
ANA-negative systemic lupus erythematosus.
Ahmed AR, Workman S. Ahmed AR, et al. Clin Exp Dermatol. 1983 Jul;8(4):369-77. doi: 10.1111/j.1365-2230.1983.tb01795.x. Clin Exp Dermatol. 1983. PMID: 6605221 No abstract available.
ANA-negative SLE.
Maddison PJ. Maddison PJ. Clin Rheum Dis. 1982 Apr;8(1):105-19. Clin Rheum Dis. 1982. PMID: 6749392 Review. No abstract available.
ANA-negative systemic lupus erythematosus.
Fessel WJ. Fessel WJ. Am J Med. 1978 Jan;64(1):80-6. doi: 10.1016/0002-9343(78)90181-x. Am J Med. 1978. PMID: 304670
The presence of antinuclear antibodies (ANA) in serum is generally considered a decisive diagnostic sign of systemic lupus erythematosus (SLE). Ten patients with clinical signs of disease but persistent negative tests for ANA are examined …
The presence of antinuclear antibodies (ANA) in serum is generally considered a decisive diagnostic sign of systemic lupus
ANA-Negative Hydralazine-Induced Pericardial Effusion.
Zeitjian V, Mehdizadeh A. Zeitjian V, et al. Case Rep Med. 2017;2017:3521541. doi: 10.1155/2017/3521541. Epub 2017 Dec 17. Case Rep Med. 2017. PMID: 29391867 Free PMC article.
This case describes a patient with pericardial effusion as a phenomenon of the drug-induced lupus erythematosus (DILE) syndrome due to hydralazine. The relevance of this case report lies in the fact that although hydralazine has been a known causative agent of DILE, …
This case describes a patient with pericardial effusion as a phenomenon of the drug-induced lupus erythematosus (DILE) syndrom …
ANA Negative Systemic Lupus Erythematosus Leading to CTEPH, TTP-Like Thrombocytopenia, and Skin Ulcers.
Changal KH, Sofi F, Altaf SS, Raina A, Raina AH. Changal KH, et al. Case Rep Rheumatol. 2016;2016:4507247. doi: 10.1155/2016/4507247. Epub 2016 Feb 24. Case Rep Rheumatol. 2016. PMID: 27006850 Free PMC article.
During its clinical course periods of flares may alternate with periods of remission culminating in disease and therapy related damage. We describe a case of ANA negative SLE with severe thrombocytopenia, cutaneous vasculitis, antiphospholipid antibody syndrome, and …
During its clinical course periods of flares may alternate with periods of remission culminating in disease and therapy related damage. We d …
Antinuclear antibody-negative lupus? An ominous presentation of hydralazine-induced lupus syndrome.
Solomon-Tsegaye T, Treadwell EL, Obi R, Pitzalis M. Solomon-Tsegaye T, et al. Eur J Rheumatol. 2018 Dec;5(4):272-274. doi: 10.5152/eurjrheum.2018.18040. Epub 2018 Jun 20. Eur J Rheumatol. 2018. PMID: 30071945 Free PMC article.
Up to 10% of systemic lupus erythematosus (SLE) cases are drug-induced; hence, they are called drug-induced lupus syndrome (DILS). Antinuclear antibody (ANA) should be present to diagnose SLE and DILS. ANA-negative lupus is …
Up to 10% of systemic lupus erythematosus (SLE) cases are drug-induced; hence, they are called drug-induced lupus
133 results